Safinamide Mesylate

CAS 202825-46-5 10 current records 1 historicalSmall Molecule

Who holds supplier records for Safinamide Mesylate? 10 organisations hold a current record for Safinamide Mesylate: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (7), Poland (1) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Safinamide Mesylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/safinamide-mesylate

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Safinamide Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India7Poland1China1Country not recorded for 1
Need Safinamide Mesylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Safinamide Mesylate are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Germany · Inactive DMF 28157 · filed Jun 2014

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Safinamide Mesylate is a selective monoamine oxidase B (MAO-B) inhibitor with both dopaminergic and non-dopaminergic properties. It is primarily used in the treatment of Parkinson's disease as an add-on therapy to levodopa/carbidopa.

Chemical identity

IUPAC name
(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic acid
Canonical SMILES
C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O
InChIKey
YKOCHIUQOBQIAC-YDALLXLXSA-N
Synonyms
Xadago API, nw 1015, nw-1015, pnu 151774e, pnu-151774e, safinamide mesilate, safinamide methanesulfonate, safinamide methansulfonate, xadago

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Monoamine Oxidase Type B Inhibitor
Mechanism of action
Breast Cancer Resistance Protein Inhibitors; Monoamine Oxidase-B Inhibitors

Therapeutic areas

NeurologyMovement DisordersParkinson's Disease

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Safinamide Mesylate?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Safinamide Mesylate: MSN LIFE SCIENCES PRIVATE LIMITED (India), APICORE PHARMACEUTICALS PRIVATE LIMITED (India), APITORIA PHARMA PRIVATE LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), HOSTER LABS PRIVATE LTD (India), OPTIMUS DRUGS PRIVATE LTD (India), SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD and SOLARA ACTIVE PHARMA SCIENCES LTD (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Safinamide Mesylate Drug Master Files are active?

MSN LIFE SCIENCES PRIVATE LIMITED (DMF 33725, 34628), APICORE PHARMACEUTICALS PRIVATE LIMITED (DMF 34399), APITORIA PHARMA PRIVATE LTD (DMF 35179), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 35201), HOSTER LABS PRIVATE LTD (DMF 40110), OPTIMUS DRUGS PRIVATE LTD (DMF 35138), SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD (DMF 44437) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 35719) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Safinamide Mesylate records mean?

1 organisation has only inactive Type II DMFs for Safinamide Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Safinamide Mesylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Safinamide Mesylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.